Company’s Game-changing Innovation Leverages the Latest AI, Autonomous Mobility Technology and Conversation Services for a Smarter Life at Home SEOUL, South Korea, Dec. 27, 2023 /PRNewswire/ — LG Electronics (LG) is ready to unveil its innovative smart home Artificial Intelligence (AI) agent at CES 2024. LG’s smart home AI agent boasts robotic, AI and multi-modal… Continue reading LG USHERS IN ‘ZERO LABOR HOME’ WITH ITS SMART HOME AI AGENT AT CES 2024
Category: Newswire
Rx-360® anuncia su junta directiva para 2024
FILADELFIA, 26 de diciembre de 2023 /PRNewswire/ — Rx-360® tiene el agrado de anunciar su junta directiva para 2024. Como organización sin fines de lucro, la junta directiva esta en una posición ideal para seguir impulsando la misión de cadena de suministro farmacéutica, calidad de materiales y seguridad de los pacientes de Rx-360®. Este anuncio llega después… Continue reading Rx-360® anuncia su junta directiva para 2024
Rx-360® anuncia o conselho de administração para 2024
FILADÉLFIA, 27 de dezembro de 2023 /PRNewswire/ — Rx-360® tem o prazer de anunciar seu conselho de administração para 2024. Como uma entidade sem fins lucrativos, o conselho de administração está posicionado para continuar a conduzir a missão do Rx-360® de segurança da cadeia de abastecimento farmacêutica, qualidade dos materiais e segurança do paciente. Este anúncio acompanha… Continue reading Rx-360® anuncia o conselho de administração para 2024
Rx-360® Announces 2024 Board of Directors
PHILADELPHIA, Dec. 27, 2023 /PRNewswire/ — Rx-360® is pleased to announce its 2024 Board of Directors. As a non-profit, the Board of Directors is positioned to continue driving the Rx-360® mission of pharmaceutical supply chain security, material quality, and patient safety. This announcement follows the organization’s successful growth in 2023. The Rx-360® 2023 Board of Directors includes: Scott… Continue reading Rx-360® Announces 2024 Board of Directors
Rx-360® gibt den Vorstand für das Jahr 2024 bekannt
PHILADELPHIA, 27. Dezember 2023 /PRNewswire/ — Rx-360® freut sich, den Vorstand für das Jahr 2024 bekanntzugeben. Der Vorstand der Non-Profit-Organisation Rx-360® hat die Aufgabe, die Mission der Materialqualität und Patientensicherheit für die pharmazeutische Lieferkette kontinuierlich zu fördern. Diese Bekanntgabe folgt auf das erfolgreiche Wachstum der Organisation im Jahr 2023. Der Vorstand von Rx-360® für das Jahr 2023… Continue reading Rx-360® gibt den Vorstand für das Jahr 2024 bekannt
Rx-360® annonce son conseil d’administration pour 2024
PHILADELPHIE, 27 décembre 2023 /PRNewswire/ — Rx-360® a le plaisir d’annoncer son conseil d’administration pour 2024. En tant qu’organisation à but non lucratif, le conseil d’administration est bien placé pour poursuivre la mission de Rx-360®, à savoir assurer la sécurité de la chaîne d’approvisionnement pharmaceutique, la qualité des matériaux et la sécurité des patients. Cette… Continue reading Rx-360® annonce son conseil d’administration pour 2024
Law Offices of Jason Turchin Expands National Product Liability Division to Combat a Wide Range of Defective Products
FORT LAUDERDALE, Fla., Dec. 27, 2023 /PRNewswire/ — The Law Offices of Jason Turchin is proud to announce the expansion of its National Product Liability division, now extensively covering a multitude of sectors affected by defective products. This expansion is a testament to the firm’s commitment to consumer safety and accountability in manufacturing. Consumer ProductsOur enhanced… Continue reading Law Offices of Jason Turchin Expands National Product Liability Division to Combat a Wide Range of Defective Products
Rx-360® anuncia su Junta Directiva 2024
FILADELFIA, 27 de diciembre de 2023 /PRNewswire/ — Rx-360® se complace en anunciar su Junta Directiva 2024. Como organización sin ánimo de lucro, la junta directiva está posicionada para continuar impulsando la misión de Rx-360® de seguridad de la cadena de suministro farmacéutica, calidad de los materiales y seguridad del paciente. Este anuncio sigue al exitoso… Continue reading Rx-360® anuncia su Junta Directiva 2024
Everest Medicines Announces New Drug Application Acceptance of Nefecon® in Taiwan for the Treatment of Primary IgA Nephropathy in Adult Patients
SHANGHAI, Dec. 26, 2023 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that its New Drug Application (NDA) for Nefecon® has been accepted for review by the Taiwan Food and Drug Administration (TFDA) for the treatment of… Continue reading Everest Medicines Announces New Drug Application Acceptance of Nefecon® in Taiwan for the Treatment of Primary IgA Nephropathy in Adult Patients
Adamastor commits to Hi-rEV, the agenda for the recovery of the automotive components sector
PORTO, Portugal, Dec. 26, 2023 /PRNewswire/ — Adamastor recently took part in the “European Conference on the Structural Integrity of Additively Manufactured Materials”, thus signalling its involvement in the Hi-rEV project – Recovery of the Automotive Components Sector, the agenda for the recovery of the automotive components industry. Continue Reading Frederico Ribeiro, Engineering Director at… Continue reading Adamastor commits to Hi-rEV, the agenda for the recovery of the automotive components sector